Press release
Oncology Biosimilars Market Research Report 2021 Growth, Recent Trends and Forecast to 2025 - Dr. Reddy's Laboratories Ltd., Pfizer, Inc., Sandoz International GmbH
MarketInsightsReports has published a report titled Oncology Biosimilars Market research report 2021 that is a detailed observation of several aspects, including value, volume, recent market trends, and different methodologies implemented by the primary market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a structured approach to the current and prospective scenario of this market.Oncology Biosimilars Market report provides impact of the Novel COVID-19 pandemic on the market, as well as rise and fall during the forecast period.
The global Oncology Biosimilars Market was valued at USD 1.65 billion in 2017 and is projected to grow at a CAGR of over 25.0% during the forecast period 2020 to 2025.
Top Companies in the Global Oncology Biosimilars Market are
Dr. Reddy's Laboratories Ltd., Pfizer, Inc., Sandoz International GmbH, Amgen Biosimilars, Intas Pharmaceuticals Ltd., Samsung Bioepis Co. Ltd., Celltrion Inc., Teva Pharmaceutical Industries Ltd, and Others.
This report elaborates the market size in USD Million, market characteristics, and market growth of the Oncology Biosimilars industry, and breaks it down according to the types of therapies and application, and consumption areas or avenues.
Click here to get a free latest sample copy of Oncology Biosimilars Market updated research 2021 before purchase
https://www.marketinsightsreports.com/reports/03202714318/2020-2025-global-oncology-biosimilars-market-report-production-and-consumption-professional-analysis-impact-of-covid-19/inquiry?mode=72&source=openPR
Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product.
Types of the Oncology Biosimilars Market are
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
Other
Applications of the Oncology Biosimilars Market are
Retail pharmacies
Hospital pharmacies
Online pharmacies
Other
News Updates
- June 11, 2020 / NEW YORK / FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA
Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved NYVEPRIA, a biosimilar to Neulasta…
For more information use referral link below
- August 05, 2020 / Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and biopharmaceutical company Alvotech today announced that they have entered into an exclusive strategic partnership for the commercialization in the U.S. of five biosimilar product candidates…
For more information use referral link below
Browse Full Report Description with TOC
https://www.marketinsightsreports.com/reports/03202714318/2020-2025-global-oncology-biosimilars-market-report-production-and-consumption-professional-analysis-impact-of-covid-19?mode=72&source=openPR
Regions covered By Oncology Biosimilars Market Report 2021 To 2026 are
Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), North America (United States, Canada, and Mexico), Central & South America (Brazil, and Rest of South America), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other).
Objectives of the Oncology Biosimilars market report is
- A comprehensive evaluation of all opportunities and risks in the market.
- Oncology Biosimilars market current developments and significant occasions.
- The deep study of business techniques for the development of the market-driving players.
- Conclusive study about the improvement plot of market for approaching years.
- Top to bottom approach of market-express drivers, targets, and major littler scale markets.
Frequently Asked Questions about the Oncology Biosimilars market:
- What are the recent developments and government policies?
- What are the top trends in the Oncology Biosimilars market?
- What is the growth rate of the market?
- Which Is the most potential market segment?
- Which are the top industry players in the Oncology Biosimilars market?
- Which region would offer high growth for vendors in the market?
References and Sources
https://www.businesswire.com/news/home/20200611005430/en/FDA-Approves-Pfizer%E2%80%99s-Oncology-Supportive-Care-Biosimilar-NYVEPRIA%E2%84%A2-pegfilgrastim-apgf
https://www.tevapharm.com/news-and-media/latest-news/teva-and-alvotech-announce-strategic-partnership-to-collaborate-in-the-u.s.-biosimilar-market/
Related Reports
Global Oncology/Cancer Drugs Sales Market https://www.marketinsightsreports.com/reports/05272938035/global-oncology-cancer-drugs-sales-market-report-2021?source=OpenPRR&mode=72
Global Oncology Drug Discovery Services Market
https://www.marketinsightsreports.com/reports/05272940512/global-oncology-drug-discovery-services-market-2021-by-company-regions-type-and-application-forecast-to-2026?mode=72&source=openPR
Free customization of the report: This report can be further customized according to the client’s specific requirements. No additional charges will be added for limited additional research.
Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States
Contact US :
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market Research Report 2021 Growth, Recent Trends and Forecast to 2025 - Dr. Reddy's Laboratories Ltd., Pfizer, Inc., Sandoz International GmbH here
News-ID: 2294153 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for Biosimilar
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
